BioCentury
ARTICLE | Clinical News

Ceprotin regulatory update

April 2, 2007 7:00 AM UTC

FDA approved Ceprotin human protein C concentrate to treat severe congenital protein C deficiency. The human protein C product, which has Orphan Drug status in the U.S., was approved in Europe in 2001...